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Summary.-Electron spin resonance spectra have been obtained from samples of
frozen whole blood or separated blood cells and plasma. Blood samples were
obtained from human controls having no diagnosed malignancy and from patients
with a variety of benign and malignant tumours.
The characteristic spectrum from control blood shows two main lines with
g values of 4-2 and 2-049. Several smaller lines can also be observed. The line at
g = 2-049 may be due to the copper protein ceruloplasmin. Although no qualitative
differences could be found between the spectra from controls and cancer patients,
samples from patients with certain types of tumour showed a significant increase
in size of the g = 2-049 signal above control values. This was most noticeably the
case with Hodgkin's disease and to a lesser extent with cancers of the breast. Squam-
ous cell carcinomata, taken as a group, did not show an elevation in average size of
the g = 2-049 signal. In this latter group, however, there were some indications
that the effects of chemotherapeutic treatment could be followed during the early
stages of such treatment. Examples are given in which onset of treatment with
various cytotoxic agents was associated with reduction in size of the g = 2-049 signal.
AT the present time a concentrated
effort is being made to try to find evidence
of chemical or physical alterations in the
blood which may occur during thedevelop-
ment of carcinogenesis. Such findings
couldbe ofvalue in assisting with diagnosis
and possibly even in treatment of cancer.
Many examples of work in this field have
been published, e.g. that of Hughes (1971)
who has studied serum concentration of
a range of immunoglobulins in patients
with a variety of malignant conditions;
Rudman et al. (1971) have examined the
plasma amino acids in human blood
during acute leukaemia and Ababei,
Moisiu and Chisleag (1971) have looked
at glucose-6-phosphate phosphohydrolase
activity in erythrocytes in both human
and rat cancer cases.
Unfortunately, however, few of these
studies can offer much of clinical rele-
vance although many of them have shown
very positive correlations between the
substances involved and certain stages
of carcinogenic process. The main diffi-
culties seem to be of 3 types. First the
specificity the reaction occurring in only
a small number of cases, or with only one,
or a few types of tumour. Secondly, the
substances may only be found at certain
limited times during carcinogenesis, and
thirdly they are often extremely complex
and time consuming techniques. An ex-
ample can be seen in the work of Field
and Caspary (1970) on lymphocyte sensi-
tization. Although this technique will
undoubtedly have great clinical value it
is, as it stands, totally unsuited for use
in mass screening for cancer. Electron
spin resonance (ESR) spectroscopy is a
technique which can easily be adapted for
use in general screening or as a diagnostic
aid.
Although detailed studies of ESR
spectra have been made from a fairly
wide variety of tissues in both animals
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and humans, it is noticeable that detailed
surveys ofthe ESR spectrum from human
blood are lacking in the literature.
Because of the possibility of using
ESR as a screening or diagnostic tech-
nique, and because ofthe lack ofadequate
data in the overall spectrum of human
blood, a survey was undertaken of whole
ESR spectra from both normal volun-
teers and patients with a range of malig-
nant diseases.
MATERIALS AND METHODS
Sampling techniqueandanalysis.-Samples
of approximately 1 ml of whole blood were
drawn from patients chosen to cover a
variety of different tumours. These were
all patients in the Malignant Diseases Unit
of the Aberdeen Royal Infirmary. Similar
samples were also drawn from the investiga-
tors, staff volunteers and volunteer patients
with non-malignant conditions. These latter
had all been admitted for examination and
treatment for various dental complaints.
With this latter group care was taken to
sample blood only from cases in as normal a
state as possible. Any patient receiving
drugs or having recently undergone surgery
was eliminated from this sample. The
majority were patients being examined for
mechanical injury.
In all cases the blood was withdrawn by
venous puncture and was transferred directly
from the syringe into a standard 3 mm
cylindrical ESR quartz sample tube. It
was immediately immersed in liquid nitrogen
where it remained until being placed into the
ESR cavity. The sample was not allowed
to thaw during transfer and the cavity was
for all normal examinations maintained at
a temperature of - 180°C by means of a
cold nitrogen gas stream flowing through a
dewar insert in the cavity. Spectra were
obtained using a Decca X3 spectrometer
operating in homodyne mode at 9270 MHz
with 100 KHz field modulation and a maxi-
mum incident power of 50 mW. A modula-
tion amplitude of 20 G peak-to-peak was
normally used. A standard rectangular
Decca cavity was used, operating in TE012
mode with an unloaded Q-factor of approxi-
mately 8000. The signal was normally
averaged over 10 sweeps using an Inter-
technique SA 40B multi-channel analyser,
and finally transferred to punch tape for
computer analysis. Sweeps of 0-4000 G
were made on each specimen, followed by
more detailed study of selected areas of the
spectrum. Sizes of the signals are given as
peak-to-peak heights. Since the shape of
the various components appears to remain
constant despite variations in size, these
figures should bear a direct relationship to
the number ofspinspresent.
A total of 137 cases were examined in this
way, in many instances several samples of
blood being obtained from the same case
over a period of time. A summary of the
numbers in each of the main groups is given
in Table I. In addition to those shown a
wide variety of other tumours, mainly malig-
nant, were examined. These included lym-
phosarcomata, a smooth muscle sarcoma,
neuroma, cylindroma, teratoma, etc. In all
cases notes were made of any treatment
received by the patient before sampling and,
if several samples were taken, all treatment
received during the sampling period.
TABLE I.-Main Groups of Blood Samples
Group
Control
Squamous cell carcinoma
Breast carcinoma
Benign lesions ofbreast
Malignant melanoma
Bronchial carcinoma
Hodgkin's disease
Rodent ulcer
RESULTS
Signalsfrom normal blood
No. ofs-amples
23
28
37
4
8
6
3
8
Samples were obtained from a total
of 23 controls. In several cases more
than one sample was removed, with
intervals of at least a week between
sampling. This enabled checks to be
made on consistency of signal in the
blood of various individuals. In one case
10 samples were removed at intervals of
approximately one month throughout the
period of this study. Such a series not
only enables a study of consistency to be
made, but also provides a check on the
apparatus in addition to taking normal
cavity background spectra.
Averages of all the control spectra
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Cavity Background
Average Control Blood
-> H
t
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FiG. 1.-Full length spectrum from control blood. Spectrum obtained by computer averaging
of all signal-averaged spectra from control samples. Power level 50 mW. Background is that
of cavityplus sample tube. Sweep 0-4000 G.
are shown at 2 different machine settings
in Fig. 1 and 2. Fig. 1 shows the total
length of spectrum obtainable with the
apparatus used in these experiments;
Fig. 2, represents in more detail the
spectrum between 3 0 and 3-5 KG.
Examination of the long spectrum
normally showed only 2 obvious lines.
The g values of these were 2-049 and
approximately 4-2. Examination of the
region ofg 4-2 in greater detail normally
showed that this signal was a single line.
There was usually nothing else in the
t >H
50G
g=2.16
FIG. 2.- Details of control blood spectrum (com-
puter average of signal-averaged spectra).
Sweep starting at 3- 0 KG, power level 50 mW.
spectrum in this area. However, as is
shown in Fig. 2, considerably more detail
could be seen in the general region of the
g _ 2*049 signal. Smaller signals were
found with g values of 2-16, 2*005 and
1-98. Although, as will be mentioned
later, other signals were occasionally
observed in the blood, these were the
only consistent signals present.
In an attempt to identify these
signals further a large sample of blood
was taken and centrifuged to separate
blood cells from plasma, care being taken
to keep haemolysis to a minimum. A
small amount of anticoagulant (heparin)
had to be used but a comparison ofspectra
from the same volunteer with and without
heparin indicated that the anticoagulant
did not affect the whole blood ESR
spectrum in any way. Spectra run on the
2 components separately (Fig. 3) showed
that the signal at g - 2005 was present
in the cell fraction, this being even more
clearly established in a sweep from 3.2 KG
upwards, with a reduced power level, and
it was present to only a very small extent
in the plasma fraction. The signal at
g-2 16 was part of the cavity back-
ground signal.
In the plasma the signals were at
g 4-2 and g - 2-049 (both of these
were represented by only very small
components in the cells-possibly due to
the small amount of plasma left in that
fraction since the cells were not washed).
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FIG. 3.-Separation of signals in plasma and cell
fractions of control blood. Sweep starting at
3*0 KG, power level 50 mW. Background is
that of cavity plus sample tube.
this fraction, although small. It was not
found at all in the cell fraction. The
reason for reduction in size of this signal
after separation is unknown.
Investigation of the saturation of the
signals at g = 2-005 and g = 2-049 was
FIG. 4.-Saturation curves of g = 2-049 signal
(full line) and g = 2-005 signal (broken line).
made (Fig. 4) by obtaining spectra at
different incident power levels ranging
from 50 mW to 50 ,uW and at 2 differ-
enttemperatures, - 180°C and - 90°C. The
results were plotted as S/VP against
power level. This should remain flat
in the absence of saturation. It was
found that whereas the graph for g
2-005 fell rapidly at higher power levels
at both temperatures, indicating a marked
saturation, thegraphforg = 2-049 showed
very little decrease over the range at
- 90°C and only a slight falling off at
higher power levels at - 180C. This
would suggest that the half saturation
power is much higher than 50 mW.
From this information it is possible
to offer some suggestion as to the origin
of the major signals in the blood. The
signal at g = 2-005 shows the same plac-
ing and saturation characteristics that are
usually associated with the free radicals
produced as semiquinonesduringoxidative
metabolism. The fact that the signal is
mainly localized in the cell fraction, where
one would expect to find it in the white
blood cells, strengthens this conclusion.
The signal at g 1-98 is very similar to
signals found in that region in rat liver
and other tissues. For example Mallard
and Kent (1966) found a signal in the
same tissue at g = 1-98 and Ruuge and
Chetverikov (1970) found a signal in
rat liver at g = 1-97. These signals are
normally suggested to originate from iron,
often associated with the microsomal
fraction of the tissue, although this can-
not be the case in the blood plasma.
The plasma signal at g 4 2 is also
most likely to be a paramagnetic com-
plex including ferric iron. Signals of
approximately this g value have been
reported in tumour tissue by Nebert and
Mason (1963) and by Mallard and Kent
(1966). Most workers, however, appear
not to have examined this part of the
spectrum. Nebert and Mason suggested
that the signal is associated with high
spin (ionic) iron and in their case it was
localized in the rough microsomal fraction
of the tumorous tissues. The plasma
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TABLE II.-Individual Variation ofSize of Main Signals
Case No. 9
g'.4-2 g-=2049
4 94 6-48
6-03 4 97
4 39 6-07
3-92 6-19
5-39 3-44
4-34
3-47
- 900
- 6-29
Average 4- 84 5- 74
signal is likely to be from iron of a similar
configuration, although in a different
protein complex.
The signal at g = 2f049 is more
debatable in its origins. Its saturation
characteristics and g value suggest that
once again it is a paramagnetic complex
and it would appear likely, in this region
of the spectrum, that it could be due to a
copper-containing protein. (Mailer, 1973,
personal communication). It is worth
noting that Walaas, Lovstad and Walaas
(1967) obtained a signal of g value 2-057
from solutions of pure ceruloplasmin, and
Ingram (1969) discusses values of 2*209
and 2-056 for this compound. We did
not detect a signal in the plasma with a
g value in the region of 2-2 but in view of
the localization of the g = 2-049 signal
in the plasma and the similarity in
g value to that obtained from pure
ceruloplasmin we suggest that this is a
possible source of this signal. The level
of copper in the plasma is sufficient to
account for a signal of this size (94.3 Utg/
100 ml plasma-Hrgovcic et al., 1968)
and 96% of this copper is bound to
ac2+3-globulin in the form of ceruloplas-
min. This copper-containing serum en-
zyme acts as a ferroxidase and is the
molecular link between copper and iron
metabolism in the body (Frieden, 1970).
However, more work is needed in this
field before the identification can be made
with any certainty.
Case No. 132
g 4-2 g= 2-049
5-31 3-08
4 26 4-31
4-24
Average 4- 79 3.54
Case No. 4
4-51
3-57
- 4-39
3-53
Average 4- 00
Individualvariation
Table II shows the variation in signal
size of the 2 main signals in 3 of the
controls from whom multiple samples were
obtained. These variations are fairly
representative of the group as a whole.
As can be seen, there is considerable
alteration of size of both signals although
this tends to be much less in the case ofthe
g 4-2 signal than for that at g _ 2-049.
It should be noted that the overall average
for the g = 2-049 signal in the 3 cases is
different. Cases No. 132 and No. 10
were male volunteers while case No. 9
was a female. Although the general
control averages for male and female were
very similar, this particular female was
takingcontraceptive steroids. Itisknown
that steroids cause an increase in cerulo-
plasmin level in the blood (Russ and
Raymunt, 1956; Gault, Stein andAronoff,
1966), and this could probably account
for the overall elevation of the signal,
if this is indeed due to ceruloplasmin.
The reasons for the variations are as
yet unknown since the ceruloplasmin
level of the blood normally does not show
any great variation in ahealthyindividual.
As was mentioned previously, certain
samples showed signals in regions of the
spectrum other than those already des-
cribed. The most common of these was
at approximately g = 2-1, although an-
other was occasionally seen in the region
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TABLE III.-Relative Size of g- 2049 Signal
Type
Control
Total ofconfirmed
malignancies
Breast cancer
Squamous carcinoma
Malignant melanoma
Hodgkin's disease
Number
26
63
22
19
7
3
Mean
4-83
5-69
5-87
5-06
5-36
7-02
to be linked with those at g = 2-049
and g ' 4-2 respectively and they were
found in control and non-control blood
alike. No explanation can be offered for
these signals at the present time.
Signalsfrom blood of tumour patients
Despite our hopes at the beginning
of this investigation, the spectra from the
controls and the tumour cases were
essentially similar in content. That is,
no extra lines were found in association
with all or any particular type of tumour,
neither were any of the normal lines
absent. Since this was the case, the
signals were then examined for variations
in amplitude. The signals at g =_ 1-98
and 2005 were too small to allow any
detailed analysis to be made although
they both appeared to be present and of
the same order of size in both controls
and tumour patients. The signal at
g , 4-2 was sufficiently large and isolated
to enable a more detailed studytobemade.
However, no significant overall difference
in size could be detected for this signal.
Examination of the g 2-049 signal,
however, did show significant differences
between the average control spectrum
size and the average from the tumour
patient samples (in taking this latter
value only data from confirmed malig-
nancies were included, benign lesions and
unconfirmed cases being omitted). The
data are given in Table III. It can be
seen that there is a significant difference
between the average control value and
that for the average of the malignancies.
This being the case, it was decided to
break the data down further and examine
the various types of malignancy to see
Standard error
of mean
0 325
0-241
0-384
0 433
0 524
0 667
Standard
deviation
1-66
1-91
1-80
1-88
1-28
1*15
Significance c/f
control value
<005
<0 05
N.S.
N.S.
<0-01
ifanyhadahigher significance than others.
As can be seen from the table very general
classification was used. It was found that
cancers of the breast, taken as a whole,
showed a significant difference from the
mean control value. However, neither
squamous cell carcinoma nor malignant
melanoma showed any significant varia-
tion from the controls. These were the
only tumour types where enough data
were available to make a reasonable
estimate of significance. However, the
data for Hodgkin's lymphoma are also
included even though only 3 cases were
examined. This is because, despite the
small sample, the size of the g _ 2*049
signal was sufficiently elevated above that
of the controls to give a very high signi-
ficance to the variation.
Variation in the amplitude of a signal
in this region has been reported by other
workers (Swartz and Wiesner, 1972), who
found a signal in blood plasma with a
g value of approximately g- 205. From
the shape of this signal it would appear
to be the same as the g = 2-049 signal
of our work. They found highly signifi-
cant differences in signal size between
controls and patients with bronchogenic
cancer, and suggest that this is common
to all cancer patients. However, they
comment on the variability of this effect
and the difficulties in interpretation due
to the wide varieties of tumours, different
stages of tumourogenesis and different
clinical states of the patients concerned.
These same difficulties were encountered
in our work and undoubtedly gave rise
to the large variability in signal size.
More work in this field, along with more
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studied, could perhaps reduce the errors.
Further work by the above group (Mailer,
1972, personal communication) has shown
that high levels ofsignificance ofdifference
can be found with squamnous cell carcin-
oma, adenocarcinoma andlymphoma when
compared with controls. Presumably
their group of adenocarcinoma includes,
among others, the breast cancers. If so,
we would be in agreement on the signi-
ficance of the difference in this group.
Unfortunately we did not find any sign-
ficant elevation of the signal size with the
average figure for patients with squamous
cell carcinoma, but within this group we
found a very wide variation between
individual results. Fig. 5 shows the
distribution of heights for the controls,
the cell carcinomata and the breast
cancer samples. It can be seen that the
controls (as was also reported by Swartz
aand WAiesner, 1972) show a definitely
Breast
Cancer
X~Iho
Control l
x
0-1 1-2 2-3 3-4 4-5 5-6 6-7 7-8 8-9 9-10
Relative size of signal
Fi(e. 5. Distribution of ielative size of signials
obtained from control blooct an(l bloodl from
patients wvith breast cancer ancd squiamous cell
carcinoma. Each point repIesents oine patient.
bimodal distribution. The breast cancer
samples show a more normal distribution
but the squamous cell carcinoma results
are split into 2 parts, with one group
centred around a relative height of 4
and another group at about 8. Because
ofthis uneven distribution the significance
figures shouldbeviewedwith some caution.
Further analysis of the squamous cell
carcinoma data showed some interesting
indications. Of the 5 very high values,
one was from an unannotated case early
in the study. Of the remaining 4, 3
were cases in which spreading into the
nodes had occurred. In only one case
in the size 4-5 section of the group was
there spreading to nodes in a patient
who was not receiving treatment at the
time of sampling. In one other case in
this size range thesample wastaken several
days after removal of the affected tissue
by block dissection. In one of the cases
in the high group, Case No. 92, samples
were taken before and after block dlissec-
tion of the affected lymph nodes. Three
days before removal a height of 8382
was recordedI but by 4 days after removal
this had dropped to 4-12. Also among the
squamous cell carcinoma group were
3 patients receiving treatment with cyto-
toxic (Irugs, 2 cases (Nos. 39 and H3)
with methotrexate and one (No. 41)
with cyclophosphamide. Of these, Cases
113 and 41 gave the 2 lowest readinigs of
the entire sample, one of2-96 and the other
of 2-30. The third patient, receiving
methotrexate, had only a partial course
and because of reaction against the drug
treatment had to be interrupted. The
sample was taken some days after cessa-
tion of treatment in this case, and the size
of the signal was 4-52. This patient was
readmitted 4 months later with spreading
to the nodles and represents one of the
high values mentioned above. Several
patients were receiving, or had just
finished, courses of radiotherapy at the
time of sampling. None of these showed
any significant decrease or elevation of
the signal size from the average of the
group, other than Case No. 113 who was
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also receiving methotrexate. This is at
variance with the report of Swartz and
Wiesner who found a significant decrease
in siginal size from squiamous cell car-
cinoma patients receiving radiotherapy.
WVe were utniable to find similar correlations
between therapy and signal size among
the breast cancer patients, although it
should be noted that once again the
lowest signal size recorded, that of 2-73
for Case No. 48, was from a patient
receiving 5rS-fluorouracil treatment.
Finally, note should be taken of the
highly significant increase in signal size
in patients with Hodgkin's disease. This
type of l-mphoma has been investigated
from the point of view of serum copper
levels byT several workers, including Hrgo-
vcic et al. (1 968), wlho found that although
patients with inactive Hodgkin's disease
had plasma copper levels within the
normal range, samples taken during active
phases of the disease showed a very high
serum copper level, ranging from 172
to 426 pgg/ 100 ml. Although our results
do not show such a dramatic alteration
in signal size this, along with such work
as that of Gulko (1961), who showed that
there is some elevation in blood copper
levels in a variety of cancer patients, they
would add strength to the suggestion
that the g = 2 049 signal arises from
ceruloplasmin.
CONCLUSIONS
As was stated in the introduction,
we were hoping to find some way in
which ESR could be used as a screening
or diagnostic technique for cancer. Un-
fortunately our study of blood, although
by no means complete as yet and using
only a smnall number of samples, has
already shown that the method reported
in this paper is unlikely to fulfil the condi-
tions requiired for mass screening for
malignancies in general. There are three
main difficulties to be overcome, even
though significant differences have been
found between blood of patients with
various types of tumours and that of
controls. These difficulties are (1) that
the differences are in signal size rather
than in signal content of the spectrum
and hence not so easily observable, (2)
that the size difference is a fairly small
one, averaging no more than 2000, and
(3) that there is a wide spread of signal
size in both control and tumour groups.
The technique, however, has shown
indications of both diagnostic and treat-
ment monitoring functions. In the latter
case there are indications of variations of
signal size with treatment, particularly
during chemotherapy. As regards use
as a diagnostic method, there is already
good evidence that certain types of
malignancy, e.g. Hodgkin's disease, show
abnormal ESR signals in the blood.
Although there is a wide spread of control
values, such groups as breast tumours
showed an overall elevation in signal size.
The bimodal distribution of the control
results confuses these results but if the
reason for this pattern could be found then
it is possible that differences from normal
could appear more marked, hence making
the ESR blood technique a more valuable
tool.
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